stella
beta
Neoadjuvant Envafolimab Plus Disitamab Vedotin and Carboplatin in Resectable HER2-Mutant Non-Small-Cell Lung Cancer — Stella
Recruiting
Back to Non-small Cell Lung Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Guangdong Provincial People's Hospital, Guangzhou
View full record on ClinicalTrials.gov